Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,703 | 390 | 97.7% |
| Education | $182.99 | 5 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $826.61 | 52 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $808.09 | 52 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $743.85 | 46 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $731.25 | 45 | $0 (2024) |
| Medtronic, Inc. | $544.89 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $537.26 | 25 | $0 (2024) |
| Amgen Inc. | $515.63 | 27 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $443.07 | 18 | $0 (2024) |
| Edwards Lifesciences Corporation | $405.41 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $319.51 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,645 | 80 | PFIZER INC. ($299.96) |
| 2023 | $1,828 | 93 | E.R. Squibb & Sons, L.L.C. ($275.92) |
| 2022 | $1,736 | 90 | E.R. Squibb & Sons, L.L.C. ($306.23) |
| 2021 | $785.33 | 45 | Janssen Pharmaceuticals, Inc ($189.80) |
| 2020 | $428.53 | 24 | PFIZER INC. ($89.09) |
| 2019 | $1,029 | 48 | Abbott Laboratories ($192.97) |
| 2018 | $434.45 | 15 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($148.25) |
All Payment Transactions
395 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $38.30 | General |
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.57 | General |
| 12/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Boston Scientific Corporation | RESONATE EL ICD VR (Device) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: RESONATE_CRM | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Pacemakers | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Cardiovascular | ||||||
| 10/08/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Not Applicable | ||||||
| 09/27/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $27.01 | General |
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Obesity | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: Cardiovascular | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.91 | General |
| Category: Cardiovascular | ||||||
| 09/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Not Applicable | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,398 | 5,043 | $1.2M | $290,812 |
| 2022 | 25 | 3,406 | 5,089 | $1.3M | $312,920 |
| 2021 | 26 | 3,148 | 4,730 | $1.1M | $307,007 |
| 2020 | 25 | 2,454 | 3,401 | $604,617 | $228,668 |
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 501 | 865 | $345,902 | $81,810 | 23.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 197 | 502 | $185,238 | $49,273 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 135 | 235 | $131,600 | $33,166 | 25.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 149 | 154 | $95,987 | $23,490 | 24.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 134 | 136 | $73,032 | $19,171 | 26.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 551 | 1,097 | $50,462 | $12,491 | 24.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 223 | 224 | $46,816 | $12,153 | 26.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 46 | $30,452 | $8,151 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 56 | 67 | $29,681 | $7,700 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 37 | 37 | $20,794 | $5,206 | 25.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 556 | 789 | $20,514 | $5,187 | 25.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 56 | 59 | $19,116 | $5,030 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $18,792 | $4,173 | 22.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 61 | 61 | $14,213 | $3,736 | 26.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $12,120 | $3,028 | 25.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 25 | 40 | $9,842 | $2,468 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $9,632 | $2,304 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 29 | $8,758 | $2,235 | 25.5% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 21 | 22 | $7,392 | $1,871 | 25.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 79 | 79 | $5,135 | $1,335 | 26.0% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 66 | 68 | $5,372 | $1,299 | 24.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 59 | 59 | $4,484 | $1,199 | 26.7% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 14 | 29 | $4,988 | $1,093 | 21.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 88 | 88 | $3,784 | $961.87 | 25.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 60 | 63 | $3,402 | $910.12 | 26.8% |
About Dr. Anoop Patel, M.D
Dr. Anoop Patel, M.D is a Internal Medicine healthcare provider based in Towson, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1629367123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anoop Patel, M.D has received a total of $7,886 in payments from pharmaceutical and medical device companies, with $1,645 received in 2024. These payments were reported across 395 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,703).
As a Medicare-enrolled provider, Patel has provided services to 12,406 Medicare beneficiaries, totaling 18,263 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Towson, MD
- Active Since 04/05/2011
- Last Updated 11/19/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629367123
Products in Payments
- ELIQUIS (Drug) $950.10
- XARELTO (Drug) $727.80
- ENTRESTO (Drug) $614.77
- LifeVest (Device) $443.07
- Repatha (Biological) $408.85
- MYCARELINK (Device) $380.95
- CAMZYOS (Drug) $323.16
- VYNDAQEL (Drug) $287.22
- JARDIANCE (Drug) $220.91
- Vascepa (Drug) $215.40
- CardioMEMS HF System (Device) $192.97
- FARXIGA (Drug) $182.59
- MULTAQ (Drug) $152.17
- Arcalyst (Drug) $134.55
- SAPIEN 3 Ultra RESILIA (Device) $124.68
- NEXLETOL (Drug) $121.36
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $118.19
- LEQVIO (Drug) $116.48
- BRILINTA (Drug) $111.39
- Corlanor (Drug) $106.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Towson
Vikas Kalra, Md, MD
Internal Medicine — Payments: $20,342
Dr. Syed Zaidi, M.d, M.D
Internal Medicine — Payments: $20,308
Dr. David Edwards, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $14,404
Albert Deloskey, M.d, M.D
Internal Medicine — Payments: $14,028
Latrica Cook, M.d, M.D
Internal Medicine — Payments: $8,868
Madhat Arnouk, M.d, M.D
Internal Medicine — Payments: $8,212